Volume Spike Investor

Acura Pharmaceuticals Inc. (NASDAQ: ACUR) is getting crushed this morning after an FDA advisory panel recommended that the FDA not approve its new opioid painkiller Acurox. Its partner King Pharmaceuticals Inc. (NYSE: KG) is also down on the news.  Average volume in Acura is only 130,000 shares and the 52-week trading range was $4.00 to [...]

King Pharmaceuticals Inc. (NYSE: KG) volume exploded on August $10 calls with nearly 4,000 trading before 10:30 AM as a rumor that Abbott Labs (NYSE: ABT) is looking at the Company for a $16.00 offer.  Implied volatility initially turned higher from 91% to 98%.  King shares are cheap on most metrics and it trades just [...]

King Pharmaceuticals Inc. (NYSE: KG) stock fell more than 2 percent to $9.12 in after hours trading as one of the more active issues. The company said an FDA panel is requiring more study of its heart-imaging candidate Corvue. The FDA said King failed to show Corvue worked as well as the approved drug adenosine [...]

There are several stocks this morning seeing rather large moves based on analyst calls rather than on news out of the companies themselves.  These are the price change indications as of 8:25 AM EST: Arena Pharmaceuticals (NASDAQ: ARNA) Cut to Sell from Hold at Canaccord Adams; shares down almost 4%. Exxon Mobil (NYSE: XOM) Started [...]

Alpharma inc. (NYSE: ALO) isn’t exactly your run of the mill “most active” stock, but it is this morning.  King Pharmaceuticals (NYSE: KG) has offered to buy the drug company in a $1.4 Billion buyout valuing the company at $33.00 in cash per share.  Shares are already up over that level at $34.20 after ten [...]